BEIJING, April 14 (Xinhua) -- Boasting a wide issuer coverage, bond issuance has been adopted as an important financing tool supporting COVID-19 epidemic prevention and control of related enterprises in the first quarter.
As Securities Daily reported Tuesday that 153 bond products for epidemic prevention and control were issued by enterprises in China's Shanghai and Shenzhen bourses from January to March, raising a total of 143.20 billion yuan in the period.
By April 13 this year, 185 bond products for the COVID-19 prevention and control have been issued to raise 152.41 billion yuan of funds, with 60 ones of them being 5-year or longer term bonds and 94 of them enjoying auction yields lower than four percent.
Characterized by high efficiency, low costs and large value, bonds for the COVID-19 prevention and control whose proceeds are strictly required to be used or partly used for the epidemic control work, well supported corporate financing, said an industry analyst. (Edited by Duan Jing with Xinhua Silk Road, duanjing@xinhua.org)
A single purchase
